


Forta Bio Revenue
Biotechnology Research • San Francisco, California, United States • 1-10 Employees
Forta Bio revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Forta Bio
Marcin Kortylewski
Co-Founder
Company overview
| Headquarters | San Francisco, California, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Biotech, Cancer Therapies, Targeted Medicine, Autoimmune Diseases Therapies, In-Vivo Genetic, Oligonucleotide Therapies |
| Founded | 2025 |
| Employees | 1-10 |
About Forta Bio
Forta Bio is a next-generation biotech company developing precision therapies that selectively eliminate disease-driving immune and cancer cells — without compromising healthy immunity. Our proprietary cell targeting 6tdGO DNA platform uses a dual mechanism of action to directly disrupt telomeres in specific TERT+ cells while activating the body’s immune response. This approach is uniquely suited for treating aggressive cancers and autoimmune diseases. We focus on high-burden, underserved conditions — particularly those affecting women and children — and pursue accelerated regulatory pathways. Backed by validated science from City of Hope and led by a team with 7+ INDs, 30+ pharma deals, and multiple biotech exits, Forta Bio is on a mission to bring smarter, safer, and more targeted therapies to patients who need them most.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Forta Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Forta Bio has never raised funding before.
Frequently asked questions
4.8
40,000 users



